Conclusion metronidazole and vancomycin have good evidence for use in rcdi but heterogeneity in treatment duration and dose precludes robust conclusions. Fid i i v i f fidaxomicin vs vancomycin for clostridium difficile infection geriatric grand rounds journal club 92112 carly lam m. Two recently completed phase 3 trials 003 and 004 showed fidaxomicin to be noninferior to vancomycin for curing clostridium difficile infection cdi and superior for reducing cdi recurrences. Cornely oa, crook dw, esposito r, poirier a, somero ms, weiss k, sears p, gorbach s. Common questions about clostridium difficile infection. C 2, 18 tapering and the pulseddose method of oral vancomycin therapy for second recurrences of. In settings where access to vancomycin or fidaxomicin is lim ited, we. Two recently completed phase 3 trials 003 and 004 showed fidaxomicin to be noninferior to vancomycin for curing clostridium difficile infection cdi and. The newest treatment strategy for clostridium difficile. Fidaxomicin versus vancomycin in the treatment of clostridium difficile infection. Fidaxomicin was noninferior to vancomycin with respect to clinical cure rates in the treatment of clostridium difficile infections cdis in two phase iii trials, but was associated with significantly fewer recurrences than vancomycin.
Pdf fidaxomicin versus vancomycin in the treatment of. Fidaxomicin vs vancomycin for clostridium difficile. Safety and efficacy of fidaxomicin and vancomycin in. Fidaxomicin versus vancomycin for clostridium difficile infection article pdf available in new england journal of medicine 3645. This analysis examined the efficacy of fidaxomicin versus vancomycin in 406 canadian patients with clostridium difficile infection cdi, based. Canadian outcomes table 3 clinical response and sustained clinical response of subgroups within the modified intentto. Guidelines for the treatment of clostridium difficile. Nucleic acid tests detect the gene that produces the toxin that causes c. Management of clostridiodes difficile infection ahrq. Clostridium difficile was first recognized as the cause of antibioticassociated colitis in 1977. Guidelines for current treatment of clostridium difficile infection.
Significantly fewer patients in the fidaxomicin group than in the vancomycin group had a recurrence of the infection, in both the modified intentiontotreat analysis 15. Treatment with fidaxomicin resulted in significantly higher rates of resolution of diarrhea without recurrence than did treatment with vancomycin. In general, strive to use antibiotics covering a spectrum no. Fid i i v i f fidaxomicin vs vancomycin for clostridium difficile. Antiperistaltic agents and opiates should be avoided. Fidaxomicin versus vancomycin for clostridium difficile. Louie tj1, miller ma, mullane km, weiss k, lentnek a, golan y, gorbach s. This economic analysis investigated the costeffectiveness of fidaxomicin compared with vancomycin in patients with severe cdi and in patients with. Treatment of recurrent clostridium difficile infection department of. Treatment of first recurrence of clostridium difficile infection. But not all treatment failure and relapse due to bi strain. Table 3 fidaxomicin versus vancomycin in the treatment. Fidaxomicin, a narrowspectrum antibiotic approved for clostridioides clostridium difficile infection cdi in adults, is associated with lower rates of recurrence than vancomycin. Clinical practice guidelines for clostridium difficile infection in.
233 1086 643 1274 551 1423 122 287 264 664 1253 299 457 1441 1178 574 366 89 349 1423 964 521 1380 179 57 567 283 298 56 1443 712 77